Panelists discuss the progress and partnerships made by pharmaceutical companies, government, academia, and investors in the fight to control and end the pandemic, and offer ideas on how…
Steven Quay, MD, PhD, physician-scientist and CEO of Atossa Therapeutics, discusses ongoing clinical trials of two treatments for patients infected with SARS-CoV-2 and how certain therapeutics will continue…
The Covid-19 Early Treatment Fund was launched to provide funding for research in order to "find an existing drug or drug combination that, when given early, reduces hospitalization…
In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Andrew Krivoshik, MD, PhD, Oncology Therapeutic Area Head at Astellas Pharma, discusses acute myeloid leukemia (AML) in the context of the COVID-19 pandemic. The prevalence of healthcare disparities…